濮阳东方医院在线咨询(濮阳东方看妇科价格低) (今日更新中)

BEIJING, March 22 (Xinhuanet) -- An autopsy began Monday on Berlin zoo's superstar polar bear Knut who died suddenly on Saturday, media reports said.However, it remained unclear when the results from the post-mortem examination of Knut would be published."I cannot give you a timeline. We will inform the public when we know what the exact cause was," AFP quoted spokeswoman Claudia Bienek as saying.Knut died while sunbathing at Berlin zoo in Germany in front of visitors. The four-year-old swivelled around several times before falling backwards into the water in his enclosure.Witnesses said he suffered a series of convulsions and appeared to have had an epileptic fit or a heart attack.Knut was born in 2006 to a female bear who rejected him at birth. He was hand-raised by his keeper at the zoo. Films were made about him and he appeared on the front cover of Vanity Fair magazine and earned the zoo about 7.11 million U.S. dollars.More than 15,000 Knut fans have so far paid tribute to him on Berlin zoo's website. Hundreds more have flocked to the zoo in person to lay flowers at his enclosure.

WASHINGTON, April 6 (Xinhua) -- A study led by researchers at the University of Michigan (U-M) showed in animal studies that new cancer drug compounds they developed shrank tumors, with few side effects.The study, done in two mouse models of human cancer, looked at two compounds designed to activate a protein that kills cancer cells. The protein, p53, is inactivated in a significant number of human cancers. In some cases, it is because another protein, MDM2, binds to p53 and blocks its tumor suppresser function. This allows the tumor to grow unchecked. The new compounds block MDM2 from binding to p53, consequently activating p53."For the first time, we showed that activation of p53 by our highly potent and optimized MDM2 inhibitors can achieve complete tumor regression in a mouse model of human cancer," says lead study author Shaomeng Wang, director of the Cancer Drug Discovery Program at the U-M Comprehensive Cancer Center.Wang presented the study Wednesday at the American Association for Cancer Research 102nd annual meeting.Many traditional cancer drugs also activate p53 but they do so by causing DNA damage in both tumor cells and normal cells, causing side effects. These new MDM2 inhibitors activate p53 while avoiding the DNA damage common with other drugs. In this study, which was done in collaboration with Ascenta Therapeutics and Sanonfi-Aventis, researchers showed that these new drugs shrank tumors without significant side effects.Because p53 is involved in all types of human cancer, the new drug has potential to be used in multiple types of cancer. Further, the researchers also identified certain markers in tumors that predict which ones will be particularly sensitive to the MDM2 inhibitor, which would allow physicians to target the drug only to patients most likely to benefit.

N'DJAMENA, Feb. 16 (Xinhua) -- Chadian President Idriss Deby Itno said Wednesday while meeting visiting Chinese Foreign Minister Yang Jiechi that his country is willing to expand cooperation with China in infrastructure building, agriculture, health care and other fields.During the meeting with Yang, who arrived here Tuesday for an official visit, the president said the Chadian-Chinese relations are based on equality, mutual respect and noninterference in each other's interior affairs. He said China has successfully completed a number of aid projects in Chad, which greatly facilitated the social and economic development of the African country.Deby said Chad is willing to boost cooperation with China in such areas as infrastructure construction, agriculture and health care, and hopes to strengthen coordination with China on international affairs.For his part, Yang said Chad has undertaken the path of national reconciliation, political stability and social progress under the leadership of President Deby, and has made significant achievements in economic development and improvement of the welfare of the Chadian people.He said bilateral relations are developing rapidly since the re-establishment of diplomatic ties, with cooperation and exchanges at different levels significantly increased. The two sides have improved mutual political trust, supported each other on matters regarding each other's core interests, and seen continuous progress in trade and economic cooperation, said the foreign minister.Yang said China sees Chad as an important partner in Africa, and China is willing to further boost mutual political trust with Chad, expand trade and cooperation in infrastructure building, telecommunications as well as education sectors.The visiting Chinese FM also met with his Chadian counterpart Moussa Faki Mahamat Wednesday on further improving bilateral relations and cooperation.

BEIJING, Jan. 28 (Xinhua) -- China will further its efforts to harness the Huaihe River over the next five to 10 years in a bid to support the economic development of the regions along the river.The decision was announced Friday in a statement released after an executive meeting of the State Council, China's Cabinet, which was presided over by Premier Wen Jiabao.The work will include upgrading dams and water gates in flood diversion programs and building more irrigation and water conservancy projects in low-lying lands along the Huaihe River, said the statement.Further, efforts will be made to guard against water pollution and help urban and rural residents in the Huaihe River regions have sufficient access to clean water, it said.Also, more flood control reservoirs will be constructed, while more residents will be relocated from flood diversion areas as well as flood land.The cabinet urged government departments to earmark more funds and enhance management and cooperation in implementing these measures.The 1,000-kilometer Huaihe River, the third longest water way in China, originates from Mount. Taibai, central Henan Province, and runs eastward between the Yangtze River and the Yellow River, the two largest rivers in the country. It cuts through Henan and east China's Anhui and Jiangsu provinces before entering the Yangtze River via the Hongze Lake.The flood-prone river has a drainage area of about 180,000 square kilometers.

BEIJING, March 3 (Xinhuanet) -- A new study suggested that regular use of painkiller ibuprofen may cut the risk of developing Parkinson's disease, according to Reuters reports.The research findings were published in the online edition of the journal Neurology on Wednesday and later will appear in the print edition on March 8.The study, which followed more than 136,000 U.S. men and women for six years, showed that people who took ibuprofen at least twice a week were 38 percent less likely to develop Parkinson's, a brain disorder that causes tremors and movement problems, compared to those who didn't take the pain reliever so often.Ibuprofen is sold in the U.S. as a non-steroidal anti-inflammatory drug (NSAID). But the study didn't prove that other NSAIDS, like aspirin or naproxen, could also cut the Parkinson's risk."Our study suggests ibuprofen could be a potential neuroprotective agent against Parkinson's," says lead researcher Dr. Xiang Gao from Harvard Medical School, "Protective effects are seen after taking ibuprofen two or more times a week. That's so-called regular use."However, he also warned that no proof has been found that ibuprofen itself can help ward off Parkinson's, and said that it's too early to recommend people to start taking ibuprofen to protect against the disorder.Gao said, "We just see an association, not some causal relationship."Besides, regular ibuprofen use has risks, like stomach bleeding and kidney damage.

来源：资阳报